The article discusses the challenges involved in developing nanopharmaceutical technologies from the lab to clinics. Topics include the development of novel emulsification technology for microsphere formulation and has expanded to include encapsulation technology at the nanoscale; and Pfizer used the technology as a method for creating Covid-19 vaccine formulations containing mRNA encapsulated by lipid nanoparticles.
Processing Request
No Comments.